Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Beta thalassemia: molecular pathogenesis and clinical variability].

A E Kulozik1

  • 1Abteilung Pädiatrie II, Universität Ulm.

Klinische Padiatrie
|July 1, 1991
PubMed
Summary

Beta-thalassaemia severity varies greatly due to diverse beta-globin gene mutations. Understanding the molecular defect-clinical picture link is crucial for managing this genetic blood disorder.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The beta thalassaemia trait in Jamaica.

Journal of community genetics·2023
Same author

Hb Santa Juana (<i>β</i> 108(G10) Asn > Ser): a low oxygen affinity hemoglobin variant in a family of Bosnian background.

Hematology (Amsterdam, Netherlands)·2023
Same author

The haematology of Jamaicans: red cell indices in HbAA, HbAS, HbAC, and HbA-HPFH genotypes.

Journal of community genetics·2022
Same author

Thrombocytosis in children and adolescents-classification, diagnostic approach, and clinical management.

Annals of hematology·2021
Same author

Genomic profiling of Acute lymphoblastic leukemia in ataxia telangiectasia patients reveals tight link between ATM mutations and chromothripsis.

Leukemia·2017
Same author

Identification of a genetically defined ultra-high-risk group in relapsed pediatric T-lymphoblastic leukemia.

Blood cancer journal·2017

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Context:

  • Homozygous beta-thalassaemia presents with severe anemia, often requiring transfusions.
  • Significant clinical variability exists, from severe symptoms to asymptomatic cases.
  • Reduced beta-globin synthesis leads to excess alpha-globin chains and ineffective erythropoiesis.

Purpose:

  • To review the relationship between molecular defects and clinical manifestations in beta-thalassaemia.
  • To explore how various beta-globin gene mutations influence disease presentation.
  • To discuss factors affecting alpha-globin chain excess and clinical outcomes.

Summary:

  • Beta-thalassaemia involves numerous beta-globin gene mutations affecting globin synthesis at multiple levels.
  • Clinical presentation is primarily determined by the specific inherited mutations.
  • Co-inheritance of alpha-thalassaemia or hereditary persistence of fetal globin can modify the clinical picture.

Impact:

  • Provides insights into genotype-phenotype correlations in beta-thalassaemia.
  • Highlights the importance of molecular diagnostics for predicting clinical severity.
  • Informs personalized treatment strategies for beta-thalassaemia patients.

Related Experiment Videos